Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Bergonié
Elevation Oncology
Sarcoma Oncology Research Center, LLC
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
Rain Oncology Inc
University of Virginia
Pfizer
Albert Einstein College of Medicine
Children's Oncology Group
pharmaand GmbH
Hoffmann-La Roche
City of Hope Medical Center
Nektar Therapeutics
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Pfizer
University of South Florida
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Columbia University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
GE Healthcare
INSYS Therapeutics Inc
Pfizer